Wells Fargo initiated coverage on Mineralys Therapeutics with a new price target

3/7/23 7:40:52 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Wells Fargo initiated coverage of Mineralys Therapeutics with a rating of Overweight and set a new price target of $27.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$MLYS

Date	Price Target	Rating	Analyst
6/11/2025	$15.00	Hold	Jefferies
7/10/2024	$30.00	Buy	H.C. Wainwright
4/2/2024	$30.00	Buy	Goldman
3/7/2023		Outperform	Evercore ISI
3/7/2023	$39.00	Buy	BofA Securities
3/7/2023	$32.00	Buy	Guggenheim
3/7/2023	$27.00	Overweight	Wells Fargo
3/7/2023	$45.00	Buy	Stifel